Prescriptions made by Dale Glenn Schaefer

Data for 2018

881

Medicare Part D Prescriptions Filled, Including Refills

Rank: 205 out of 956 providers in this state and specialty

$390.8K

Total Retail Price of All Prescriptions

Rank: 81 out of 956 providers in this state and specialty

359

Patients Receiving at Least One Drug in Part D

Rank: 175 out of 956 providers in this state and specialty

-

Average Risk Score

Not enough data available

74

Average Age of Patients

Average age of patients for providers in this state and specialty is 73

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Dermatology in Texas and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 DOXYCYCLINE HYCLATE490
of 5910
970 prescriptions
Less than 1% of all prescriptions
970420 patients
12% of all patients
420 patients
12% of all patients
A
2 TRIAMCINOLONE ACETONIDE1730
of 7910
960 prescriptions
Less than 1% of all prescriptions
710 patients
20% of all patients
< 11
3 FLUTICASONE PROPIONATE30
of 500
850 prescriptions
Less than 1% of all prescriptions
690 patients
19% of all patients
< 11
4 METRONIDAZOLE520
of 4390
440 prescriptions
Less than 1% of all prescriptions
310 patients
9% of all patients
< 11A
5 KETOCONAZOLE1540
of 6730
360 prescriptions
Less than 1% of all prescriptions
250 patients
7% of all patients
< 11
6 FLUOROURACIL720
of 4540
370 prescriptions
Less than 1% of all prescriptions
370 patients
10% of all patients
< 11
7 VALACYCLOVIR
(VALACYCLOVIR HCL)
400
of 4000
300 prescriptions
Less than 1% of all prescriptions
300180 patients
5% of all patients
180 patients
5% of all patients
8 DOXYCYCLINE MONOHYDRATE590
of 2340
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11A
9 MUPIROCIN820
of 5390
560 prescriptions
Less than 1% of all prescriptions
560400 patients
11% of all patients
400 patients
11% of all patients
10 CLOBETASOL PROPIONATE1320
of 6380
220 prescriptions
Less than 1% of all prescriptions
220150 patients
4% of all patients
150 patients
4% of all patients
11 FLUOCINONIDE910
of 4710
320 prescriptions
Less than 1% of all prescriptions
270 patients
8% of all patients
< 11
12 FINACEA
(AZELAIC ACID)
60
of 290
200 prescriptions
Less than 1% of all prescriptions
200< 11< 11
13 JUBLIA
(EFINACONAZOLE)
20
of 40
180 prescriptions
Less than 1% of all prescriptions
180< 11< 11
14 OTEZLA
(APREMILAST)
220
of 1100
180 prescriptions
Less than 1% of all prescriptions
< 11< 11
15 TACROLIMUS190
of 500
150 prescriptions
Less than 1% of all prescriptions
130 patients
4% of all patients
< 11
16 TERBINAFINE HCL290
of 1740
200 prescriptions
Less than 1% of all prescriptions
200110 patients
3% of all patients
110 patients
3% of all patients
17 CALCIPOTRIENE240
of 850
180 prescriptions
Less than 1% of all prescriptions
160 patients
4% of all patients
< 11
18 DUPIXENT
(DUPILUMAB)
150
of 390
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
19 TALTZ AUTOINJECTOR
(IXEKIZUMAB)
60
of 250
130 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
20 ULORIC
(FEBUXOSTAT)
10
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
21 ATORVASTATIN CALCIUM30
of 30
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
22 PICATO
(INGENOL MEBUTATE)
130
of 250
120 prescriptions
Less than 1% of all prescriptions
110 patients
3% of all patients
< 11